GROUP ONE TRADING, L.P. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is and the CUSIP is 00900T907. A total of 3 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$20,539,000
+1107.5%
596,200
+485.7%
0.06%
+700.0%
Q2 2020$1,701,000
+19.5%
101,800
+3.1%
0.01%
-33.3%
Q1 2020$1,423,000
-3.4%
98,700
+124.3%
0.01%
+20.0%
Q4 2019$1,473,000
+158.4%
44,000
+61.8%
0.01%
+100.0%
Q3 2019$570,000
+1440.5%
27,200
+1411.1%
0.01%
Q2 2019$37,000
+85.0%
1,800
+100.0%
0.00%
Q1 2019$20,000
-63.6%
900
-55.0%
0.00%
Q3 2018$55,000
-92.5%
2,000
-92.7%
0.00%
-100.0%
Q2 2018$734,000
+216.4%
27,300
+274.0%
0.01%
+200.0%
Q1 2018$232,000
-73.2%
7,300
-68.1%
0.00%
-66.7%
Q4 2017$866,00022,9000.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
JPMORGAN CHASE & CO 101,800$2,435,0000.00%
SIMPLEX TRADING, LLC 55$131,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AIMMUNE THERAPEUTICS INC shareholders